Gáspár, Renáta and Gömöri, Kamilla and Kiss, Bernadett and Szántai, Ágnes and Pálóczi, János and Varga, Zoltán V. and Pipis, Judit and Váradi, Barnabás and Ágg, Bence and Csont, Tamás and Ferdinandy, Péter and Görbe, Anikó (2020) Decorin Protects Cardiac Myocytes against Simulated Ischemia/Reperfusion Injury. MOLECULES, 25 (15). pp. 1-19. ISSN 1420-3049
|
Text
molecules-25-034262.pdf Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
Search for new cardioprotective therapies is of great importance since no cardioprotective drugs are available on the market. In line with this need, several natural biomolecules have been extensively tested for their potential cardioprotective effects. Previously, we have shown that biglycan, a member of a diverse group of small leucine-rich proteoglycans, enhanced the expression of cardioprotective genes and decreased ischemia/reperfusion-induced cardiomyocyte death via a TLR-4 dependent mechanism. Therefore, in the present study we aimed to test whether decorin, a small leucine-rich proteoglycan closely related to biglycan, could exert cardiocytoprotection and to reveal possible downstream signaling pathways. Methods: Primary cardiomyocytes isolated from neonatal and adult rat hearts were treated with 0 (Vehicle), 1, 3, 10, 30 and 100 nM decorin as 20 h pretreatment and maintained throughout simulated ischemia and reperfusion (SI/R). In separate experiments, to test the mechanism of decorin-induced cardio protection, 3 nM decorin was applied in combination with inhibitors of known survival pathways, that is, the NOS inhibitor L-NAME, the PKG inhibitor KT-5823 and the TLR-4 inhibitor TAK-242, respectively. mRNA expression changes were measured after SI/R injury. Results: Cell viability of both neonatal and adult cardiomyocytes was significantly decreased due to SI/R injury. Decorin at 1, 3 and 10 nM concentrations significantly increased the survival of both neonatal and adult myocytes after SI/R. At 3nM (the most pronounced protective concentration), it had no effect on apoptotic rate of neonatal cardiac myocytes. No one of the inhibitors of survival pathways (L-NAME, KT-5823, TAK-242) influenced the cardiocytoprotective effect of decorin. MYND-type containing 19 (Zmynd19) and eukaryotic translation initiation factor 4E nuclear import factor 1 (Eif4enif1) were significantly upregulated due to the decorin treatment. In conclusion, this is the first demonstration that decorin exerts a direct cardiocytoprotective effect possibly independent of NO-cGMP-PKG and TLR-4 dependent survival signaling.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | cardiac myocytes; cardio protection; ischemia/reperfusion injury; proteoglycan; decorin |
Subjects: | R Medicine / orvostudomány > RC Internal medicine / belgyógyászat R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan |
SWORD Depositor: | MTMT SWORD |
Depositing User: | MTMT SWORD |
Date Deposited: | 14 Sep 2020 14:14 |
Last Modified: | 14 Sep 2020 14:14 |
URI: | http://real.mtak.hu/id/eprint/113151 |
Actions (login required)
Edit Item |